Does BREXPIPRAZOLE Cause Electrocardiogram qt prolonged? 154 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 154 reports of Electrocardiogram qt prolonged have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 1.2% of all adverse event reports for BREXPIPRAZOLE.
154
Reports of Electrocardiogram qt prolonged with BREXPIPRAZOLE
1.2%
of all BREXPIPRAZOLE reports
0
Deaths
15
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From BREXPIPRAZOLE?
Of the 154 reports, 15 (9.7%) required hospitalization, and 2 (1.3%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BREXPIPRAZOLE. However, 154 reports have been filed with the FAERS database.
What Other Side Effects Does BREXPIPRAZOLE Cause?
Weight increased (1,589)
Product use in unapproved indication (1,188)
Off label use (937)
Akathisia (807)
Drug ineffective (730)
Tardive dyskinesia (558)
Tremor (552)
Anxiety (475)
Product use issue (434)
Suicidal ideation (427)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which BREXPIPRAZOLE Alternatives Have Lower Electrocardiogram qt prolonged Risk?
BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL
BREXPIPRAZOLE vs BRIGATINIB
BREXPIPRAZOLE vs BRILINTA
BREXPIPRAZOLE vs BRILIQUE
BREXPIPRAZOLE vs BRIMONIDINE